The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance.
about
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.Integrated stress response modulates cellular redox state via induction of cystathionine γ-lyase: cross-talk between integrated stress response and thiol metabolism.Lymphoma cells with increased anti-oxidant defenses acquire chemoresistanceThe anomalous pKa of Tyr-9 in glutathione S-transferase A1-1 catalyzes product release.Glutathione-s-transferases as determinants of cell survival and death.Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patientsThe metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase.Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compoundCombined effects of GSTP1 and MRP1 in melanoma drug resistanceGlutathione S-Transferase P1 Protects Against Amodiaquine Quinoneimines-Induced Cytotoxicity but Does Not Prevent Activation of Endoplasmic Reticulum Stress in HepG2 Cells.
P2860
Q33747440-F3CF7082-9D02-4B83-A450-4F69039C7B5EQ33944747-612DC0D1-4F6F-444F-AA6E-8A7242AACA0FQ34810063-C6820BCE-ADCB-4289-9AA2-A0E5AEDACFD4Q35751025-8F0F6826-EB19-4E2D-805A-995D41289ABCQ35801960-06DFE4D4-ED94-4E00-A8D9-A7573F9D6267Q35902785-31AA9CAD-2208-4765-BA08-32E324D4E681Q35933692-DF6D6790-7E69-406D-AA6D-35646ABF04ABQ36326547-4D69B172-FCCA-44C9-A1DB-12DA70CC9D7AQ36613823-51B8BD57-B0FD-41E3-B59F-7E458E99DB38Q36996450-EE7AA7E2-B16A-45A7-9A00-A2D4C8D9716BQ37074663-4920713D-8641-4848-95F2-5E0735A5D334Q40401556-D3C6D9AA-816A-421E-90B3-3EB3ECA461A9Q52714421-8C14E6D6-1D17-414A-88F8-45374C63419E
P2860
The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The influence of coordinate ov ...... e products on drug resistance.
@ast
The influence of coordinate ov ...... e products on drug resistance.
@en
type
label
The influence of coordinate ov ...... e products on drug resistance.
@ast
The influence of coordinate ov ...... e products on drug resistance.
@en
prefLabel
The influence of coordinate ov ...... e products on drug resistance.
@ast
The influence of coordinate ov ...... e products on drug resistance.
@en
P2093
P1476
The influence of coordinate ov ...... e products on drug resistance.
@en
P2093
P304
P407
P577
2000-08-01T00:00:00Z